首页> 外国专利> Hepatitis c virus epitopes specific for cd4+ t-cell lymphocytes

Hepatitis c virus epitopes specific for cd4+ t-cell lymphocytes

机译:cd4 + t细胞淋巴细胞特异的丙型肝炎病毒表位

摘要

Hepatitis C virus (HCV) epitopes that are specific for CD4+ T lymphocytes and have an impact factor (IF) at least equal to the mean value (MW) of all IF plus two standard deviations (SD) are new. Hepatitis C virus (HCV) epitopes that are specific for CD4+ T lymphocytes and have an impact factor (IF) at least equal to the mean value (MW) of all IF plus two SD. IF is defined as IF = (n1 + 1.5n2)/m x 100 where n1 = number of reactions where the stimulation index (SI) was over 3 but less than 6; n2 = number of reactions where SI was over 6; m = number of tests carried out with a particular peptide and is at least 15. Independent claims are also included for the following: (1) vaccine that contains at least one (A); (2) diagnostic kit that contains at least one (A); (3) cDNA (B) that encodes (A); and (4) vaccine that contains at least one (B).
机译:CD4 + T淋巴细胞特有的,影响因子(IF)至少等于所有IF的平均值(MW)加上两个标准差(SD)的丙型肝炎病毒(HCV)表位是新的。特异性针对CD4 + T淋巴细胞的丙型肝炎病毒(HCV)表位,其影响因子(IF)至少等于所有IF加上两个SD的平均值(MW)。 IF定义为IF =(n1 + 1.5n2)/ m x 100,其中n1 =刺激指数(SI)大于3但小于6的反应数; n2 = SI大于6的反应数; m =用特定肽进行的测试次数,至少为15。以下还包括独立权利要求:(1)包含至少一种(A)的疫苗; (2)诊断试剂盒,其中至少包含一个(A); (3)编码(A)的cDNA(B); (4)包含至少一种(B)的疫苗。

著录项

  • 公开/公告号EP1357127A1

    专利类型

  • 公开/公告日2003-10-29

    原文格式PDF

  • 申请/专利权人 IMMUSYSTEMS GMBH;

    申请/专利号EP20020008033

  • 申请日2002-04-10

  • 分类号C07K14/18;A61K39/29;G01N33/576;G01N33/68;C12N15/51;A61K48/00;A61P31/14;

  • 国家 EP

  • 入库时间 2022-08-21 23:48:43

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号